Advertisement

Quest Diagnostics Incorporated DGX

Set alert

Price alert · DGX

All alert types
250.81 USD -1.01 -0.40%

At close · Nov 2

250.81 0.00 0.00%

After hours · Nov 2, 4:32 PM ET

Bid
250.65 × 200
Ask
250.97 × 100
247.71 Day range 251.98
171.18 52-week range 256.99
YTD
+44.53%
1 year
+42.55%
Open
251.60
Prev close
251.82
Mkt cap
27.68B
Vol
996.27K
Avg vol
992.70K
EPS
10.04
P/E
24.98
Div yield
1.37%
More statistics
Low
247.71
High
251.98
Forward P/E
20.94
Beta
0.55
Short ratio
3.05
Inst. own
98.91%
Dividend
3.44
Ex-div date
Oct 5, 2026
Earnings
Feb 9, 2027
50-d avg
238.54
200-d avg
212.15
1y target
257.27

1D chart

Chart tools
Interval

Signals (97)
NameTimeAgo
SMA: Bullish3:59 PM1 hour ago
SMA: Bullish3:59 PM1 hour ago
SMA: Bearish3:55 PM1 hour ago
SMA: Bearish3:55 PM1 hour ago
MACD: Sell Signal3:52 PM1 hour ago
RSI: Overbought3:46 PM1 hour ago
MACD: Buy Signal3:36 PM1 hour ago
SMA: Bullish3:35 PM1 hour ago
SMA: Bearish3:32 PM1 hour ago
MACD: Sell Signal3:19 PM2 hours ago
RSI: Overbought3:14 PM2 hours ago
MACD: Buy Signal3:13 PM2 hours ago
MACD: Sell Signal3:08 PM2 hours ago
RSI: Overbought2:50 PM2 hours ago
SMA: Bullish2:47 PM2 hours ago
SMA: Bullish2:46 PM2 hours ago
MACD: Buy Signal2:44 PM2 hours ago
RSI: Oversold2:37 PM2 hours ago
SMA: Bearish2:27 PM2 hours ago
SMA: Bullish2:26 PM2 hours ago
SMA: Bearish2:25 PM2 hours ago
MACD: Sell Signal2:25 PM2 hours ago
SMA: Bullish2:11 PM3 hours ago
SMA: Bullish2:11 PM3 hours ago
MACD: Buy Signal2:11 PM3 hours ago
SMA: Bearish2:00 PM3 hours ago
SMA: Bearish1:59 PM3 hours ago
SMA: Bullish1:58 PM3 hours ago
SMA: Bullish1:58 PM3 hours ago
SMA: Bearish1:54 PM3 hours ago
SMA: Bearish1:47 PM3 hours ago
SMA: Bearish1:46 PM3 hours ago
MACD: Sell Signal1:44 PM3 hours ago
MACD: Buy Signal1:27 PM3 hours ago
SMA: Bullish1:26 PM3 hours ago
SMA: Bullish1:25 PM3 hours ago
SMA: Bearish1:22 PM3 hours ago
MACD: Sell Signal1:22 PM3 hours ago
SMA: Bearish1:21 PM3 hours ago
SMA: Bullish1:10 PM4 hours ago
SMA: Bearish1:09 PM4 hours ago
SMA: Bullish1:08 PM4 hours ago
SMA: Bullish1:04 PM4 hours ago
MACD: Buy Signal1:04 PM4 hours ago
SMA: Bearish1:03 PM4 hours ago
SMA: Bullish12:59 PM4 hours ago
SMA: Bearish12:51 PM4 hours ago
SMA: Bearish12:46 PM4 hours ago
MACD: Sell Signal12:39 PM4 hours ago
RSI: Overbought12:29 PM4 hours ago
RSI: Overbought12:25 PM4 hours ago
SMA: Bullish12:10 PM5 hours ago
SMA: Bullish12:10 PM5 hours ago
SMA: Bearish12:07 PM5 hours ago
SMA: Bullish12:06 PM5 hours ago
SMA: Bearish12:04 PM5 hours ago
SMA: Bullish12:03 PM5 hours ago
MACD: Buy Signal12:03 PM5 hours ago
SMA: Bearish11:46 AM5 hours ago
MACD: Sell Signal11:44 AM5 hours ago
SMA: Bearish11:42 AM5 hours ago
MACD: Buy Signal11:40 AM5 hours ago
SMA: Bullish11:37 AM5 hours ago
SMA: Bullish11:37 AM5 hours ago
SMA: Bearish11:36 AM5 hours ago
SMA: Bearish11:36 AM5 hours ago
SMA: Bullish11:35 AM5 hours ago
SMA: Bearish11:34 AM5 hours ago
SMA: Bullish11:30 AM5 hours ago
MACD: Sell Signal11:30 AM5 hours ago
SMA: Bearish11:28 AM5 hours ago
SMA: Bullish11:21 AM5 hours ago
SMA: Bullish11:19 AM6 hours ago
SMA: Bearish11:18 AM6 hours ago
SMA: Bearish11:18 AM6 hours ago
SMA: Bullish11:16 AM6 hours ago
SMA: Bearish11:14 AM6 hours ago
SMA: Bullish11:13 AM6 hours ago
SMA: Bullish11:06 AM6 hours ago
MACD: Buy Signal11:05 AM6 hours ago
RSI: Oversold10:59 AM6 hours ago
MACD: Sell Signal10:54 AM6 hours ago
SMA: Bearish10:51 AM6 hours ago
SMA: Bearish10:50 AM6 hours ago
SMA: Bullish10:47 AM6 hours ago
SMA: Bullish10:47 AM6 hours ago
MACD: Buy Signal10:47 AM6 hours ago
MACD: Sell Signal10:32 AM6 hours ago
SMA: Bearish10:31 AM6 hours ago
SMA: Bearish10:31 AM6 hours ago
SMA: Bullish10:26 AM6 hours ago
SMA: Bearish10:25 AM6 hours ago
SMA: Bullish10:18 AM7 hours ago
MACD: Buy Signal10:18 AM7 hours ago
MACD: Sell Signal10:10 AM7 hours ago
MACD: Buy Signal10:09 AM7 hours ago
MACD: Sell Signal10:06 AM7 hours ago

Key statistics

Market cap
27.69B
Enterprise value
33.70B
Trailing P/E
24.99
Forward P/E
20.94
PEG ratio
1.64
Price / sales
2.34
Price / book
3.62
EPS (TTM)
10.04
Beta
0.55
Dividend yield
1.37%
Payout ratio
25.10%
Profit margin
9.54%
Revenue (TTM)
11.84B
Revenue growth
10.00%
Free cash flow
872.50M
Total cash
797.00M
Total debt
6.40B
Return on equity
15.32%
Shares outstanding
110.37M
Short % of float
3.25%
50-day average
238.54
200-day average
212.15

Analyst view

Consensus: buy

Buy
Price target (mean) 257.27 +2.6% upside
Target (low)
235.00
Target (mean)
257.27
Target (high)
279.00
Ratings (0m) 17 9 buy · 8 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold8
  • Sell0
  • Strong sell0

Next earnings

Feb 9, 2027

Expected Feb 9, 2027. Consensus EPS estimate 2.68.

Earnings history

Financials — quick view

All financials
DGX Revenue — quarterly 3.10B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
DGX Net income — quarterly 312.00M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
DGX EPS — quarterly 2.82
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

DGX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 20262.68———
Oct 22, 2026Sep 30, 20262.873.00+0.13+4.53%
Jul 23, 2026Jun 30, 20262.823.12+0.30+10.64%
Apr 21, 2026Mar 31, 20262.372.50+0.13+5.49%
Feb 10, 2026Dec 31, 20252.362.42+0.06+2.54%
Oct 21, 2025Sep 30, 20252.502.60+0.10+4.00%

Upgrades / downgrades

DGX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026BarclaysmainOverweightOverweight
Sep 21, 2026Truist SecuritiesmainHoldHold
Sep 8, 2026UBSmainNeutralNeutral
Jul 28, 2026JP MorganmainNeutralNeutral
Jul 24, 2026UBSmainNeutralNeutral
Jul 24, 2026MizuhomainOutperformOutperform

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States

News

Your note

Sign in to keep a note on DGX — it syncs with the Stock Master app.

Insider holders

DGX insider holders
InsiderRelationLatest transactionDateShares held
DAVIS J E CAUSEYChief Executive OfficerStock Award(Grant)Mar 3, 2026142,423
DAVIS JAMES EChief Executive OfficerSaleAug 31, 2026122,423
DEPPE MICHAEL JOfficerStock Award(Grant)Mar 3, 202635,196
DOHERTY CATHERINE TOfficerSaleMar 4, 202671,624
GREGG VICKY BDirectorStock Award(Grant)Jul 21, 202618,386
MAIN TIMOTHY LDirectorPurchaseJul 21, 202627,460

Institution ownership

DGX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.43%9,275,4112.33BJun 29, 2026
Vanguard Capital Management LLC6.57%7,233,3941.81BJun 29, 2026
Vanguard Portfolio Management LLC5.57%6,131,0451.54BJun 29, 2026
State Street Corporation5.01%5,516,6431.38BJun 29, 2026
Price (T.Rowe) Associates Inc4.95%5,444,9861.37BJun 29, 2026
Boston Partners4.31%4,744,4731.19BJun 29, 2026

Fund ownership

DGX fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%3,514,526881.65MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.61%2,868,317719.55MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.18%2,398,588601.71MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.34%1,470,712368.94MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.31%1,436,934360.47MAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.25%1,373,267344.50MSep 29, 2026
Advertisement